Skip to main content
OpenTrials
Completed

NCT Number: NCT00380952

Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure

This protocol was designed for testing the intraoperative use of the Dune device. This multicenter study will take place in Israel at 12 sites.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

HaEmek Mc, Afula, Israel

Loading trial locations.

About this study

Use of the device will take place during a partial mastectomy procedure (lumpectomy).The patient will be randomized to enter the device or control arm.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Women diagnosed with carcinoma of the breast
  • Undergoing lumpectomy (local wide excision) procedure.
  • Over 18 years of age
  • Signed ICF

Exclusion criteria

  • Neoadjuvant systemic therapy
  • Previous radiation in the operated breast
  • Prior surgical procedure in the same quadrant
  • Implants in the operated breast
  • Pregnancy
  • Participating in any other investigational study for either drug or device which can influence collection of valid data under this study.

Treatment and study plan

Dune Device

Device

Sponsors and collaborators

Lead sponsor

Dune Medical Devices

Industry

Registry information

Official study title

MAST Study Protocol

Important dates

Study start
2006
Primary completion
2007
Study completion
2008
First posted
Sep 27, 2006
Registry last updated
May 28, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.